Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at cediranib and olaparib for women with womb cancer (COPELIA)

Overview

Cancer types:

Secondary cancers, Womb (uterine or endometrial) cancer

Status:

Closed

Phase:

Phase 2

Details

This trial is for women with womb cancer that has come back or spread to other parts of the body (advanced cancer). Womb cancer is also called uterine or endometrial cancer.

It is for women who have had treatment with chemotherapy that included a platinum drug in the last year.

Recruitment start: 1 May 2018

Recruitment end: 31 December 2021

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Gordon Jayson

Supported by

University of Manchester

Cardiff University

AstraZeneca

Last reviewed: 31 December 2021

CRUK internal database number: 15103

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.